Hui Luo
Jiangnan University(CN)Beijing Institute of Technology(CN)Oslo University Hospital(NO)Fujian Medical University(CN)Southwest University(CN)Minzu University of China(CN)Sun Yat-sen University(CN)Hunan University(CN)Beijing University of Chinese Medicine(CN)Yunnan University(CN)Southwest Medical University(CN)Wuhan University(CN)Zhengzhou University(CN)Shenzhen Sixth People's Hospital(CN)Jiangxi Provincial Cancer Hospital(CN)First Affiliated Hospital of Guangzhou Medical University(CN)Fifth Affiliated Hospital of Sun Yat-sen University(CN)Xiangyang Central Hospital(CN)Stomatology Hospital(CN)Cancer Hospital of Chinese Academy of Medical Sciences(CN)Sun Yat-sen University Cancer Center(CN)Shenzhen Technology University(CN)Guangdong Provincial People's Hospital(CN)Chongqing Cancer Hospital(CN)State Key Laboratory of Respiratory Disease(CN)Tongji Hospital(CN)Shougang (China)(CN)Union Hospital(CN)Anshan Hospital(CN)State Key Laboratory of Oncology in South ChinaHuazhong University of Science and Technology(CN)Guangzhou Medical University(CN)University of Lausanne(CH)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Gastrointestinal Tumor Research and Treatment
Most-Cited Works
- → Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma(2017)861 cited
- → Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma(2021)773 cited
- → DNA methylation markers for diagnosis and prognosis of common cancers(2017)490 cited
- → Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial(2020)475 cited
- → Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer(2020)431 cited
- → Molecular mechanisms of cisplatin resistance in cervical cancer(2016)414 cited